Showing results (121-130 of 133) with videos related to
Sort By:
Pageof 14
European Heart Journal. Digital Health|February 16, 2026
Development and multicentre validation of an artificial intelligence electrocardiogram model for ventricular remodeling in repaired tetralogy of FallotSon Q Duong, Akhil Vaid, Pengfei Jiang, et al.Science Advances|November 18, 2022
SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to DeltaNeeltje van Doremalen, Manmeet Singh, Taylor A Saturday, et al.JAMA Network Open|October 16, 2024
Patient-Reported Outcomes Among Adults With Congenital Heart Disease in the Congenital Heart Initiative RegistryScott Leezer, Rittal Mehta, Anushree Agarwal, et al.Biorxiv : the Preprint Server for Biology|March 2, 2022
Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19Shelly Robertson, Olivia Bedard, Kristin McNally, et al.Ebiomedicine|January 12, 2023
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patientsJames L Alexander, Benjamin H Mullish, Nathan P Danckert, et al.Proceedings of the National Academy of Sciences of the United States of America|July 27, 2005
The psychrophilic lifestyle as revealed by the genome sequence of Colwellia psychrerythraea 34H through genomic and proteomic analysesBarbara A Methé, Karen E Nelson, Jody W Deming, et al.Nature Communications|July 25, 2023
Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19Shelly J Robertson, Olivia Bedard, Kristin L McNally, et al.Circulation. Genomic and Precision Medicine|August 20, 2020
De Novo Damaging Variants, Clinical Phenotypes, and Post-Operative Outcomes in Congenital Heart DiseaseMarko T Boskovski, Jason Homsy, Meena Nathan, et al.Journal of the American Heart Association|March 26, 2025
Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan CirculationAri Cedars, Cedric Manlhiot, Bhargava Kumar Chinni, et al.Plos Genetics|February 17, 2006
Comparative genomics of emerging human ehrlichiosis agentsJulie C Dunning Hotopp, Mingqun Lin, Ramana Madupu, et al.Pageof 14